How the Enterprise Works

The purpose of the Enterprise is to accelerate the development of an HIV vaccine by building consensus in the HIV vaccine field on scientific priorities, mobilizing new resources to implement these priorities, and facilitating the rapid sharing of information that can advance the field as a whole. The Enterprise itself does not conduct research—this function remains with the Enterprise partners.

Setting Scientific Priorities

Expert working groups involving 140 scientists from 15 countries …

Read More 

Mobilizing Resources

The Enterprise engages donor governments, private philanthropies, and other potential funders …

Read More 

Improving Collaboration

To improve scientific collaboration and reduce duplication of efforts …

Read More 

All Content ©2005 - 2008 Global HIV Vaccine Enterprise